A
Anna Rita Bilia
Researcher at University of Florence
Publications - 310
Citations - 8996
Anna Rita Bilia is an academic researcher from University of Florence. The author has contributed to research in topics: Artemisinin & Artemisia annua. The author has an hindex of 45, co-authored 295 publications receiving 7487 citations. Previous affiliations of Anna Rita Bilia include University of Pisa.
Papers
More filters
Journal ArticleDOI
Essential Oils Loaded in Nanosystems: A Developing Strategy for a Successful Therapeutic Approach
Anna Rita Bilia,Clizia Guccione,Benedetta Isacchi,C Righeschi,Fabio Firenzuoli,Maria Camilla Bergonzi +5 more
TL;DR: Nanocarriers can be proposed: polymeric nanoparticulate formulations, extensively studied with significant improvement of the essential oil antimicrobial activity, and lipid carriers, including liposomes, solid lipid nanoparticles, nanostructured lipid particles, and nano- and microemulsions.
Journal ArticleDOI
Hypericins as potential leads for new therapeutics.
TL;DR: The aim of this review is to analyse the most recent advances in the chemistry and biological activities (in vitro and in vivo) of the pure naphthodianthrones, hypericin and pseudohypericin from H. perforatum.
Journal ArticleDOI
Anti-inflammatory activity of unusual lupane saponins from Bupleurum fruticescens
Maria Jose Just,María-Carmen Recio,Rosa M. Giner,M. J. Cuéllar,Salvador Máñez,Anna Rita Bilia,José-Luis Ríos +6 more
TL;DR: Extracts from Bupleurum fruticescens were examined for oral and topical anti-inflammatory activities and the BuOH extract proved to be active against carrageenan and tetradecanoylphorbol acetate acute edemas and allowed the isolation of three saponins identified by spectroscopic techniques.
Journal ArticleDOI
St. John's wort and depression: Efficacy, safety and tolerability-an update
TL;DR: St. John's wort (Hypericum perforatum L.) is a medicinal plant traditionally used, both externally and internally, in all Europe for many pathologies as discussed by the authors.
Journal ArticleDOI
Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus.
Silvia Schwarz,Daniel Sauter,Kai Wang,Ronghua Zhang,Bing Sun,Anastasia Karioti,Anna Rita Bilia,Thomas Efferth,Wolfgang Schwarz +8 more
TL;DR: It is suggested that viral ion channels, in general, may be a good target for the development of antiviral agents, and that kaempferol glycosides are good candidates for 3a channel proteins of coronaviruses.